ESTRO 2025 - Abstract Book

S906

Clinical - Haematology

ESTRO 2025

Conclusion: Superficial radiotherapy has been proved as an effective treatment in our series in terms of local control. Progression disease happened only in B-cell lymphomas. Tolerance is good with low rate of toxicity related to radiotherapy treatment. There is still a need for evidence regarding the most appropriate schedule for the treatment of this pathology.

Keywords: Lymphoma, superficial radiotherapy, skin

References: Elsayad K, et. al. Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group. Eur J Cancer. 2024 Nov;212:115064. doi: 10.1016/j.ejca.2024.115064. Epub 2024 Oct 8. Specht L, et. al.; International Lymphoma Radiation Oncology Group. Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):32-9. doi: 10.1016/j.ijrobp.2015.01.008.